Technical Analysis for MORF - Morphic Holding, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 33.13 | -0.98% | -0.33 |
MORF closed down 3.15 percent on Monday, March 18, 2024, on 71 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Fell Below 50 DMA | Bearish | -0.98% | |
MACD Bearish Centerline Cross | Bearish | -0.98% | |
NR7 | Range Contraction | -0.98% | |
NR7-2 | Range Contraction | -0.98% | |
Lower Bollinger Band Walk | Weakness | -0.98% | |
Lower Bollinger Band Touch | Weakness | -0.98% | |
Oversold Stochastic | Weakness | -0.98% | |
Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | -4.10% | |
Pocket Pivot | Bullish Swing Setup | -4.10% | |
NR7 | Range Contraction | -4.10% |
Alert | Time |
---|---|
Fell Below Lower Bollinger Band | 2 minutes ago |
Fell Below Previous Day's Low | 2 minutes ago |
Down 2 % | 2 minutes ago |
Down 1% | 2 minutes ago |
60 Minute Opening Range Breakout | about 19 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/23/2024
Morphic Holding, Inc., a biopharmaceutical company, focuses on the discovery and development of oral small-molecule integrin therapeutics. The company's lead product candidates in clinical development are MORF-720, a selective oral avb6 specific integrin inhibitor for the treatment of idiopathic pulmonary fibrosis; and a4b7 specific integrin inhibitors for the treatment of inflammatory bowel disease. Its product candidates in discovery stage include an avb1 integrin for the treatment of fibrosis; two TGF-b activations for gastrointestinal cancers and fibrosis; and other aI domain integrins. The company was founded in 2014 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Clinical Development Molecular Biology Gastrointestinal Inflammatory Bowel Disease Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Fibrosis Gastrointestinal Cancer Treatment Of Fibrosis Treatment Of Idiopathic Pulmonary Fibrosis Treatment Of Inflammatory Bowel Disease Gastrointestinal Cancers Integrin
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Clinical Development Molecular Biology Gastrointestinal Inflammatory Bowel Disease Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis Fibrosis Gastrointestinal Cancer Treatment Of Fibrosis Treatment Of Idiopathic Pulmonary Fibrosis Treatment Of Inflammatory Bowel Disease Gastrointestinal Cancers Integrin
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 63.0825 |
52 Week Low | 19.345 |
Average Volume | 561,162 |
200-Day Moving Average | 39.10 |
50-Day Moving Average | 33.80 |
20-Day Moving Average | 36.25 |
10-Day Moving Average | 35.69 |
Average True Range | 1.89 |
RSI (14) | 41.86 |
ADX | 22.62 |
+DI | 13.88 |
-DI | 22.30 |
Chandelier Exit (Long, 3 ATRs) | 34.34 |
Chandelier Exit (Short, 3 ATRs) | 39.02 |
Upper Bollinger Bands | 39.09 |
Lower Bollinger Band | 33.40 |
Percent B (%b) | 0.01 |
BandWidth | 15.71 |
MACD Line | -0.03 |
MACD Signal Line | 0.60 |
MACD Histogram | -0.63 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 35.44 | ||||
Resistance 3 (R3) | 35.63 | 35.15 | 35.11 | ||
Resistance 2 (R2) | 35.15 | 34.65 | 35.06 | 35.00 | |
Resistance 1 (R1) | 34.31 | 34.34 | 34.07 | 34.12 | 34.89 |
Pivot Point | 33.83 | 33.83 | 33.72 | 33.74 | 33.83 |
Support 1 (S1) | 32.99 | 33.33 | 32.75 | 32.80 | 32.03 |
Support 2 (S2) | 32.51 | 33.02 | 32.42 | 31.92 | |
Support 3 (S3) | 31.67 | 32.51 | 31.81 | ||
Support 4 (S4) | 31.48 |